search
Back to results

Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma (TOPIAC)

Primary Purpose

Hemodynamic Instability

Status
Withdrawn
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Tetracaine 0.5%
Lidocaine hydrochloride ophthalmic gel 3.5%
Sponsored by
University of Miami
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hemodynamic Instability

Eligibility Criteria

8 Weeks - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children with Retinoblastoma diagnosis scheduled for Intra-arterial chemotherapy under general anesthesia

Exclusion Criteria:

  • any candidate with history of allergy to anesthetics or preservatives used in local anesthetics any candidate that has a history of allergic dermatitis any candidate that has an open wound in and around the eye to be treated

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Treatment session 1a

    Arm Description

    Topical ophthalmic anesthesia to participants (#) on each session (letter) of intra-arterial chemotherapy. where #1 is the participant identifier and letter-a is the start session with study protocol (most candidates will receive more than 4 sessions in a 6 month period)

    Outcomes

    Primary Outcome Measures

    Decrease in systolic Blood Pressure
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Drop in end-tidal C02
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Decrease in lung compliance
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Decrease in oxygen saturation
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Cardiac arrythmia
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.

    Secondary Outcome Measures

    Recovery from Trigeminal-cardiac event
    Investigator will communicate when the event is over or rescue drugs given.

    Full Information

    First Posted
    November 2, 2016
    Last Updated
    April 18, 2018
    Sponsor
    University of Miami
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02955524
    Brief Title
    Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma
    Acronym
    TOPIAC
    Official Title
    Topical Anesthesia to Decrease the Trigeminal-Cardiac Reflex During Intra-arterial Injection of Chemotherapy for Retinoblastoma in Children.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2018
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    I discontinued this study because I transferred to another institution.
    Study Start Date
    March 2018 (Anticipated)
    Primary Completion Date
    June 2020 (Anticipated)
    Study Completion Date
    December 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Miami

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    Yes
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The objective of this study is to use local topical anesthesia to numb the sensory input, captured by branches of the Trigeminal nerve found on the skin in and around the eye, to decrease a hemodynamic reflex seen during placement of a catheter for intra-arterial chemotherapy (IAC) for eye tumors in children. This Trigeminal-cardiac reflex brings about hemodynamic instability during general anesthesia. Normally, one could block this sensorial input with ophthalmic peribulbar placement of local anesthetics, but these eyes have malignant growth and invasive procedures may cause more harm. The investigators are aiming to numb the sensory branches of the trigeminal nerve non-invasively and observe for any decrease in these events.
    Detailed Description
    Retinoblastoma is a rare tumor of the eye and accounts for 6% of malignancies in children less than 5 years of age. Pediatric anesthesiologists have observed a series of hemodynamic instability following the insertion of a catheter into the cavernous segment of the internal carotid artery or during manipulation of a micro-catheter into the ophthalmic artery for intra-arterial chemotherapy (IAC) of retinoblastoma cases by neuroradiologists. This reaction has been recently published in case reports and observational studies as the treatment of these tumors have moved into the interventional imaging suites. This reaction closely resembles the "diving reflex" seen when a person is submerged in cold water; known as the trigeminal-cardiac reflex. It manifests as a sudden hemodynamic disturbance in arterial blood pressure, heart rate, arrhythmia and changes in pulmonary compliance.Rescue from a trigeminal-cardiac reflex entails increasing intravascular volume, administrating mild to resuscitative doses of epinephrine and ventilatory support. Catheter manipulation around the ophthalmic artery can stimulate the afferent pathway of the trigeminal nerve, branches V1 and V2, originating around the eye to be treated.The ethmoidal nerve, from the nasal passage on the same side, is also stimulated. This in turn triggers a response by the vagus nerve with hemodynamic instability. Method: Participants are placed under general endotracheal anesthesia for this scheduled procedure. One drop of ocular antiseptic (betadine 5%) will be placed in the eye to be treated followed by a drop of topical FDA approved local anesthetic, Tetracaine 0.5%, to the nasolacrimal duct ( inner corner of the eye) on the eye to be treated. This will numb the ethmoidal nerve in the nasal passage. This is followed by 1 ml of 3.5% Lidocaine gel to the surface of the eye. This gel is placed on the surface of the eye and skin around the eye to numb V1 and V2 fibers of the trigeminal nerve. The study will observe if there is any decrease in the intensity of the reflex or incidence of the reflex during placement of the micro-catheter.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hemodynamic Instability

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Early Phase 1
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Treatment session 1a
    Arm Type
    Experimental
    Arm Description
    Topical ophthalmic anesthesia to participants (#) on each session (letter) of intra-arterial chemotherapy. where #1 is the participant identifier and letter-a is the start session with study protocol (most candidates will receive more than 4 sessions in a 6 month period)
    Intervention Type
    Drug
    Intervention Name(s)
    Tetracaine 0.5%
    Intervention Description
    One drop of 0.5% Proparacaine to nasolacrimal Duct to numb the ethmoidal nerve in the nasal passage on the side of the eye to be treated.
    Intervention Type
    Drug
    Intervention Name(s)
    Lidocaine hydrochloride ophthalmic gel 3.5%
    Other Intervention Name(s)
    Akten
    Intervention Description
    1ml of lidocaine gel is placed over the conjunctivae of the eye to be treated after the patient is under general anesthesia and before the procedure
    Primary Outcome Measure Information:
    Title
    Decrease in systolic Blood Pressure
    Description
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Time Frame
    5 seconds
    Title
    Drop in end-tidal C02
    Description
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Time Frame
    5 seconds
    Title
    Decrease in lung compliance
    Description
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Time Frame
    5 seconds
    Title
    Decrease in oxygen saturation
    Description
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Time Frame
    5 seconds
    Title
    Cardiac arrythmia
    Description
    Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
    Time Frame
    5 seconds
    Secondary Outcome Measure Information:
    Title
    Recovery from Trigeminal-cardiac event
    Description
    Investigator will communicate when the event is over or rescue drugs given.
    Time Frame
    2 minutes

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    8 Weeks
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Children with Retinoblastoma diagnosis scheduled for Intra-arterial chemotherapy under general anesthesia Exclusion Criteria: any candidate with history of allergy to anesthetics or preservatives used in local anesthetics any candidate that has a history of allergic dermatitis any candidate that has an open wound in and around the eye to be treated
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jacqueline Tutiven, MD
    Organizational Affiliation
    Director Pediatric Anesthesia Fellowship/Assistant Professor
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Norman Halliday, MD
    Organizational Affiliation
    Chief, Pediatric Anesthesiology
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    27748655
    Citation
    Scharoun JH, Han JH, Gobin YP. Anesthesia for Ophthalmic Artery Chemosurgery. Anesthesiology. 2017 Jan;126(1):165-172. doi: 10.1097/ALN.0000000000001381. No abstract available.
    Results Reference
    result
    PubMed Identifier
    22793160
    Citation
    Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG, Shields C. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 2012 Sep;10(3):175-81. doi: 10.3171/2012.5.PEDS1277. Epub 2012 Jul 13.
    Results Reference
    result

    Learn more about this trial

    Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma

    We'll reach out to this number within 24 hrs